By contrast, these cells would be highly vulnerable to suppression within the TME given their expression of multiple inhibitory receptors (PD-1, TIM-3, LAG-3 and CD39), which could render them dysfunctional and unable mediate effective tumour control in situ. This evidence concerns the gene ENTPD1 and neoplasm.